Moderna
OrganizationHeard in 93 episodes across 30 shows since Jun 2026
Moderna, Inc. is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. The company's technology platform inserts synthetic nucleoside-modified messenger RNA (mRNA) into human cells to trigger immune responses.
Episodes
This week
Share of the conversation
Expert statements
Share of the conversation
Mentions of Moderna per 1,000 mentions of anything, 7-day rolling, across the podcasts PodLume Trends follows.
Show the data
| Day | Share (7-day) | Mentions |
|---|---|---|
| Aug 12 | 0.18‰ | 1 |
| Aug 13 | 0.20‰ | 2 |
| Aug 18 | 0.12‰ | 1 |
| Aug 19 | 0.56‰ | 14 |
| Aug 20 | 1.09‰ | 17 |
| Aug 21 | 1.46‰ | 10 |
| Aug 22 | 1.49‰ | 1 |
| Aug 23 | 1.55‰ | 2 |
| Aug 24 | 1.64‰ | 2 |
| Aug 25 | 1.66‰ | 2 |
| Aug 26 | 1.35‰ | 6 |
| Aug 27 | 0.82‰ | 1 |
| Aug 28 | 0.73‰ | 8 |
| Aug 29 | 0.75‰ | 2 |
| Aug 30 | 0.74‰ | 2 |
| Sep 2 | 0.48‰ | 2 |
| Sep 3 | 0.51‰ | 3 |
| Sep 12 | 0.03‰ | 1 |
| Sep 13 | 0.07‰ | 1 |
| Sep 14 | 0.09‰ | 1 |
| Sep 17 | 0.11‰ | 1 |
| Sep 18 | 0.14‰ | 1 |
| Sep 22 | 0.08‰ | 1 |
| Sep 25 | 0.08‰ | 2 |
| Sep 27 | 0.11‰ | 1 |
| Sep 28 | 0.18‰ | 3 |
| Sep 30 | 0.29‰ | 5 |
| Oct 1 | 0.35‰ | 2 |
| Oct 2 | 0.33‰ | 1 |
| Oct 4 | 0.33‰ | 1 |
What experts have said about Moderna
29 statements · 24 positive · 4 negative · 1 mixed
Moderna shares have risen more than 500% this year.
“It has rallied more than 500% this year”
Open the episode · Accenture Gains, Synopsys Rises, Moderna Tumbles as Citi Advises Selling Following 600% RallyListen at 2:38
Moderna stock has risen nearly 600% this year.
“the stock soared more, nearly 600% this year.”
Open the episode · Moderna Falls; Robinhood, Target FluctuateListen at 1:13
Moderna shares rose nearly 600% following positive clinical data.
“They had a nearly 600% surge coming after a positive result from a positive data.”
Open the episode · Micron Jumps; Northrop Grumman, Moderna SlideListen at 4:43
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
Episodes
93 episodes featuring Moderna, newest first
- Oct 4, 2026
COVID reformers confront institutional resistance and vaccine accountabilityDarkHorse PodcastOct 4, 2026 - Oct 2, 2026
Nike stumbles as AI chips and index changes reshape marketsStock MoversOct 2, 2026 - Oct 1, 2026
AI deals lift Accenture and Synopsys as Moderna faces valuation testStock MoversOct 1, 2026 - Oct 1, 2026
Cockpit attack and Trump-Fed clash drive morning headlinesBloomberg Daybreak: US EditionOct 1, 2026 - Sep 30, 2026
AI demand lifts Micron as defense and biotech bets falterStock MoversSep 30, 2026 - Sep 30, 2026
Moderna’s rally collides with valuation risk as Robinhood expands marketsStock MoversSep 30, 2026